drugset / Trial / NCT01122199
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of the combination of two drugs called RAD001 and AMG479. This study will see what effects (good and bad) RAD001 and AMG479 have on cancer. This study will also find the highest doses of RAD001 and AMG479 that can be given without causing severe side effects.
Timeline
- Start
- 2010-05-14
- Primary completion
- 2015-01-19
- Completion
- 2015-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 5 mg | Oral |
| Subject | Ganitumab | Monoclonal antibody | 12 mg/kg | Intravenous |